Skip to search formSkip to main contentSkip to account menu

mavacoxib

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The use of population pharmacokinetics for pharmacokinetic studies in small and exotic avian species : the case of celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)
2014
2014
Köpeklerde Dejeneratif Dirsek Eklemi Bozukluğu Tedavisinde Non-steroidal Antiinflamatuar Ajan (NSAIA) Uygulanmasından Sonra Adipoz Doku Kökenli Otolog Mezenkimal Kök Hücrelerin (ADkOMKH) Faydas…
In the present study based on clinical case reports, twelve dogs (7 males, 5 females) between the ages of 5 and 11 years old… 
2012
2012
EFFICACY AND SAFETY OF MAVACOXIB IN COMPARISON WITH CARPROFEN IN THE TREATMENT OF PAIN AND INFLAMMATION ASSOCIATED WITH DEGENERATIVE JOINT DISEASE IN DOGS PRESENTED AS VETERINARY PATIENTS
2009
2009
Le mavacoxib, un AINS "cox-2" à très très longue durée d'action analgésique
Avec une demi-vie de 4o jours en moyenne, le mavacoxib ne s'administre qu'une fois par mois contre les douleurs chroniques de… 
2008
2008
The active substance of Trocoxil is mavacoxib, a non-steroidal anti-inflammatory drug (NSAID) of the coxib class (ATCvet Code QM01AH92). Mavacoxib - 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)- 1H…
  • 2008
  • Corpus ID: 45504237
Trocoxil, chewable tablets for dogs, contain mavacoxib as the active substance and the triangular shaped tablets are presented in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)